artios header image

News & Events

Artios Pharma Bolsters Board of Directors with Appointment of Chris Liu, PhD

9 April 2024 | Press release

Article-1-1-400×400

Phase 2 Study of ART0380 Plus Gemcitabine in Platinum-Resistant Ovarian Cancers Begins

11 February 2024 | Media coverage

Article-5-400×400

Artios Pharma steps up ovarian cancer fight

9 February 2024 | Media coverage

featured

Silverstein appointed Chief Financial Officer at Artios Pharma

9 February 2024 | Media coverage

Artios Pharma Strengthens Financial Leadership with Appointment of Christine Silverstein as Chief Financial Officer

7 February 2024 | Press release

New Approaches for Cancer Therapies: Targeting the DNA Damage Response

27 January 2024 | Media coverage

Article-4-400×400

Artios Presents Positive Initial Phase 1/1b Clinical Monotherapy Data for ATR Inhibitor ART0380 in Advanced Solid Tumors at the European Society of Medical Oncology Congress 2023

23 October 2023 | Press release

featured-lg

Artios to Present Initial Phase 1 Clinical Monotherapy Data for ATR Inhibitor ART0380 in Advanced Solid Tumors at the European Society of Medical Oncology Congress 2023

5 October 2023 | Press release

Article-2-400×400

Professor Sir Stephen Jackson receives a knighthood for services to innovation and research

19 June 2023 | Announcement

Article-5-400×400

IUCT-Oncopole & Artios join forces to overcome resistance to therapies for familial breast cancer

13 April 2023 | Press release

Capture

1 2 3 … 7 Next »

© Artios Pharma 2024 | Website by Granite 5

Terms & conditions | Privacy policy | Site map